BBVA USA Bancshares’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
BBVA USA Bancshares's EW Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Edwards Lifesciences (EW) stake by 2.5% in Q1 2021, selling an estimated $15.7K and leaving 7,245 shares worth $606K. The position accounts for 0.03% of the portfolio, ranked #371.
BBVA USA Bancshares first reported a position in EW in Q3 2016 and has held it in 15 quarters since. The position peaked at $678K in Q4 2020. 1,144 funds tracked by Wall St. Rank hold EW as of Q1 2021.
- BBVA USA Bancshares held 7,245 shares of Edwards Lifesciences worth $606K as of Q1 2021.
- BBVA USA Bancshares sold 186 Edwards Lifesciences shares in Q1 2021, an estimated $15.7K.
- Edwards Lifesciences made up 0.03% of BBVA USA Bancshares's portfolio in Q1 2021, its #371 holding.
- BBVA USA Bancshares first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 15 quarters since.
- BBVA USA Bancshares's Edwards Lifesciences position peaked at $678K in Q4 2020.
- 1,144 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.